Altria Market Tracker

• Flavored ENDS Guidance: FDA's draft on premarket apps stresses youth risk considerations; comments due May 11, 2026.
• Open Dockets: Input sought...

• Feb 2026: 1,759.683 – sharp rise from Jan's 1,710.004
• Dec 2025 & Nov 2025: steady at 1,707.870
• Oct 2025: 1,692.221
  Upward trend pressures tobacco margins; next data Apr 14. Key watch for Altria pricing.

Landmark verdicts against Meta and Google mirror tobacco's legal reckoning for designing addictive products harming youth.

Key parallels:

• Internal...

Heated tobacco products (HTP) deliver satisfying harm reduction for ex-smokers seeking smoking-like rituals:

• Gary Sweeney (Ireland) ended 30-year...

Cancer leaders stress their role in EU Tobacco Products Directive review:

• Tobacco as top cancer risk drives engagement in EU policy.
• Nordic cancer...

MO intraday action: Trading at $66.74, up 0.7% from low of $66.25 and down 0.7% from high of $67.22.

• Volume: 8.75M shares vs. avg 11.8M
• Key...

Stalling decline of Philip Morris International and global cigarette sales raises significant concerns about progress in global tobacco control, amid analysis of their 'aspirational' 2025 targets.

Strategic defense: Major tobacco firms seek summary judgment, claiming 1998 Master Settlement Agreement's broad release blocks Baltimore's public...

Trend alert: Latest overview of 14 reviews (2014-2023) shows nicotine e-cigarettes consistently outperform NRT, non-nicotine vapes, and behavioral...

New York State launches anti-vaping campaign with free text-based quit program Drop the Vape for youth/young adults.

• Youth trends: >13% used...

Altria's on! PLUS nicotine pouches—first FDA pilot-approved product from Helix—roll out to retailers nationwide from three states.

• Strategic...

Key draws for North American investors in tobacco:

• Robust dividends: Reliable payouts from strong cash flows, undervalued vs. peers like PMI/BAT
  -...

Global debate heats up on nicotine pouches as harm reduction tools like Sweden's snus success shows lowest smoking/cancer rates and FDA approvals...

Historical parallel: Lung damage evidence emerged in 1880s, but smoking-cancer link took ~100 years to confirm—vaping now shows similar early...

Philip Morris (PM) shines as a Zacks #2 (Buy) with VGM Score B, driven by RRP expansion like IQOS.

• Smoke-free products: 41.5% of 2025 net revenues
  -...

Leading tobacco companies, including Altria and Philip Morris, demonstrate industry resilience with significant market capitalizations and consistent dividend growth amid 2026 smoke-free strategies.

Key competitive move: Philip Morris International (NYSE:PM) opens a new Business Solutions Center in Tampa to expand its U.S. footprint.

• Hub role:...

Altria Group earns 81 RS Rating, signaling improving price performance vs. peers over 52 weeks—top stocks often exceed 80 early in moves.

Key...

• Market turmoil from Mideast war fears drove S&P 500 and Nasdaq down sharply, but consumer staples rallied including Altria.
• Altria stock closed up...

• BTI: 5.5% dividend yield
• Verizon (VZ): Slightly higher at 5.6%
• Realty Income (O): 5.3% yield
  Competitive positioning for tobacco investors amid high-yield options.